Shares of Abbott Laboratories and Reckitt Benckiser Group slid this morning following a Missouri state court granting the plaintiff a retrial in a baby formula case the companies previously won.

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as "non-core" in July as part of a ...

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as “non-core” in July as part of a ...

If the payments aren't sustainable, a high yield for a few years won't matter that much. Based on the last payment, Reckitt Benckiser Group's profits didn't cover the dividend, but the company was ...

Good morning, everybody and thank you for joining us for the Reckitt Full-year 2024 Results Presentation. For those of you that don't know me, I'm Nick Ashworth and I head up Investor Relations ...

Reckitt Benckiser’s RKT-0.04%decrease; red down pointing triangle shares rose after the company said adjusted profit beat market expectations, despite lower sales, as it continues to progress ...

HL Building Blocks Build your own portfolio with HL's specially designed fund range Wealth Shortlist A selection of funds we've researched and chosen for their long-term potential ...

Reckitt Benckiser has upped its dividend as part of efforts to revamp the business. Reckitt unveiled a strategic shift to a new operating model this year, with three segments: Core Reckitt ...

Reckitt, the maker of Dettol cleaning products and Strepsils throat lozenges, missed expectations for fourth-quarter like-for-like net sales as a late flu and cold season dented demand for its ...

Reckitt Benckiser’s profits fell short of analysts’ expectations last year, despite burgeoning hopes of a turnaround at the consumer goods giant. The owner of brands like Strepsils, Dettol and Lemsip, ...

Reckitt Benckiser (RKT) had an eventful 2024. At one point, its shares hit their lowest point in a decade after a court in Illinois ordered its nutrition subsidiary Mead Johnson to pay $60mn (£47mn) ...